Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quantitative bone ultrasonometry in climacteric women.

M Gambacciani1, C Benussi, B Cappagli

  • 1Department of Obstetrics and Gynaecology, Piero Fioretti University of Pisa, Italy. margamba@tin.it

Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry
|August 12, 2004
PubMed
Summary

Quantitative bone ultrasound (QUS) measures bone characteristics beyond density, aiding osteoporosis risk assessment. This technique effectively detects menopausal bone loss and can monitor women during menopause.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum allopregnanolone in women with postpartum "blues".

Obstetrics and gynecology·2001
Same author

The use of a starting dose of recombinant follicle stimulating hormone for controlled ovarian hyperstimulation: a randomized pilot study.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2000
Same author

Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2000
Same author

Ovarian follicular fluid contains immunoreactive estriol: lack of correlation with estradiol concentrations.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2000
Same author

Dose-response efficacy of a new estradiol transdermal matrix patch for 7-day application: a randomized, double-blind, placebo-controlled study. Italian Menopause Research Group.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2000
Same author

Effects of estradiol and raloxifene analog on brain, adrenal and serum allopregnanolone content in fertile and ovariectomized female rats.

Neuroendocrinology·2000

Area of Science:

  • Orthopedics
  • Radiology
  • Gerontology

Background:

  • Osteoporosis risk assessment is crucial, particularly in aging women.
  • Quantitative bone ultrasound (QUS) is an emerging technique for evaluating bone health.
  • Menopausal transition significantly impacts bone homeostasis.

Purpose of the Study:

  • To investigate the relationship between QUS-derived amplitude dependent speed of sound (AD-SOS) and bone mineral density (BMD) in climacteric women.
  • To assess the utility of AD-SOS in detecting menopausal bone loss.
  • To explore the influence of menopausal status and age at menopause on AD-SOS.

Main Methods:

  • Bone mineral density (BMD) measured using dual-energy X-ray absorptiometry (DXA) at lumbar vertebrae, hip neck, Ward's triangle, and trochanter.

Related Experiment Videos

  • Phalanx amplitude dependent speed of sound (AD-SOS) measured using quantitative bone ultrasound (QUS).
  • Study included 1025 climacteric women.

    • Main Results:

    • Significant relationships were found between AD-SOS and BMD at various skeletal sites, though correlation coefficients were poor.
    • AD-SOS values were higher in premenopausal women compared to perimenopausal and postmenopausal women.
    • AD-SOS decreased in postmenopausal women without hormone replacement therapy, with age at menopause being a relevant predictor.

    Conclusions:

    • QUS, specifically AD-SOS, can detect bone characteristics beyond density.
    • AD-SOS is a valuable index for identifying menopausal bone loss.
    • QUS shows potential for patient follow-up during menopausal transition and in therapeutic trials for osteoporosis.